Low-dose chest computed tomography
Low-dose chest computed tomography has been studied in 3 papers since 2023: 3 observational studies in people; 2 in the past year. The newest paper, Jun 1, 2026: “B58-22 Low Dose Non-Contrast Chest CT for Screening of Multiple Diseases With One Exam”.
3 papers study it1 findingUpdated
See all 3 papers on low-dose chest computed tomography
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“Pulmonary-kernel LDCT yielded Agatston scores consistent with ECG-gated CT, without significant differences across heart-rate, BMI, or calcium-severity subgroups.”
- 1 lab in 1 country
- Funders: National Natural Science Foundation of China and 1 more
- 1 of 1 finding with company ties
- Humans3
What did studies of low-dose chest computed tomography find?
1Studies of low-dose chest computed tomography measured one outcome, Agatston score.
Agatston score
no changein humans1
1 study
Agatston score
no changein humans1
Low-dose chest computed tomography showed no clear effect on Agatston score in humans (pulmonary-kernel non-gated low-dose chest CT vs ECG-gated CT).
“Pulmonary-kernel LDCT yielded Agatston scores consistent with ECG-gated CT, without significant differences across heart-rate, BMI, or calcium-severity subgroups.”
Human trialpulmonary-kernel non-gated low-dose chest CT vs ECG-gated CTn = 312
Research SquarePreprint